Physician profile
Cristina E Solis
NPI 1497827216
$210.47
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.38 · 2023: $141 · 2024: $57.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $28.09 | 2023 | Prolia, Evenity |
| Supernus Pharmaceuticals, INC. | $24.28 | 2024 | Qelbree |
| Inspire Medical Systems, INC. | $21.88 | 2023 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $21.64 | 2023 | Trintellix |
| Novo Nordisk INC | $18.59 | 2023 | Rybelsus, Ozempic |
| Abbott Laboratories | $17.44 | 2024 | Freestyle Libre 3 |
| Nestle Healthcare Nutrition INC. | $17.43 | 2023 | |
| Lilly USA, LLC | $17.08 | 2023 | Mounjaro |
| Idorsia Pharmaceuticals US INC | $16.41 | 2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.25 | 2024 | Xifaxan |
| Pacira Therapeutics, INC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristina Solis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.